| Pharmaceutical active ingredients: |
| Buprenorphine Hydrochloride |
| Available forms, composition and doses of Finibron: |
| N / A |
| Finibron medical category: |
| Human:Analgesics (opioid)Antidotes, detoxifying agents and drugs used in substance dependenceOpiate partial agonistsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AE01 - Buprenorphine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Buprenorphine | Buprenorphine Hydrochloride | PharmaForce |
| Buprenorphine | Buprenorphine Hydrochloride | Roxane Laboratories |
| Buprex | Buprenorphine Hydrochloride | Schering-Plough |
| Buprigesic | Buprenorphine Hydrochloride | Neon Laboratories |
| Buprine | Buprenorphine Hydrochloride | Siam Pharmaceutical |
| Magnogen | Buprenorphine Hydrochloride | Baliarda Laboratorios |
| Nopan | Buprenorphine Hydrochloride | C.T.S. Chemical Industries; Lefnin |
| Norphin | Buprenorphine Hydrochloride | Unichem Laboratories |
| Pentorel | Buprenorphine Hydrochloride | Khandelwal Laboratories |
| Prefin | Buprenorphine Hydrochloride | Key Pharma |